BRAIN Biotech AG at a Glance
We are an enzyme discovery, development and manufacturing company and a key player in the bioeconomy
| Headquarter | Zwingenberg, Germany (Hesse) |
| Year of Foundation | 1993 |
| Employees | 325 (as of September 2024) |
| Revenues | 54.6 Mio Euro (Financial Year 2023/24) |
| Specialists knowledge | Biology, microbiology, biochemistry, chemistry, bioinformatics, artificial intelligence, bioprocess engineering, food technology, analytics, etc. |
| Markets | Food & Beverages, Pharma, Life Science, Environment |
| Patents | 42 active patent families with varying numbers of individual patents |
|
Services, solutions, products
|
Manufacturing: Large-scale production and refinement of enzymes and further proteins. Enzyme technology: Discover, analyze, optimize and produce enzymes on an industrial scale in a variety of microbial production organisms. Production strain development: microorganism identification; microbial strain development (non-GMO and GMO); provision of functional biomass to optimize industrial production processes. Bioprocess development: Developing production processes on a laboratory scale; process validation and sample generation; process transfer to industrial production scale. |
|
Business segments
|
BRAINBiocatalysts BRAINBioIncubator |
BRAIN Biotech AG is the parent company of the BRAIN Biotech Group. The group´s headquarter is located in Zwingenberg, South Hesse, Germany.
BRAIN Biotech AG has been listed in the Prime Standard segment of the Frankfurt Stock Exchange since February 9, 2016 (ticker symbol: BNN; securities identification number: ISIN DE0005203947/WKN 520394).
The BRAIN Biotech Group includes (as of September 2024): AnalytiCon Discovery LLC, Biocatalysts Ltd, Biocatalysts Inc, Biosun Biochemicals Inc, WeissBioTech GmbH and Breatec B.V. (62.0 %). The companies Biocatalysts Inc., Biosun Biochemicals Inc., WeissBioTech GmbH and the investment in Breatec B.V. (62.0%) have been organizationally and legally assigned to Biocatalysts Ltd. since 1 October , 2023. AnalytiCon Discovery GmbH was merged with BRAIN Biotech AG in June 2024.